The U.S. intraoperative neuromonitoring market is expected to grow at a compound annual growth rate of more than 9 percent through 2020, based on a Orbis research report, according to medGadget.
Here are five observations:
1. An increased demand for patient safety, especially during spine surgery, is spurring market growth.
2. The insourced intraoperative neuromonitoring segment will continue to dominate the market, accounting for more than 50 percent of the market in 2015.
3. Of service providers, about 61 percent provide intraoperative neuromonitoring services for neurosurgeries.
4. Since the U.S. market is led by manufacturers, local service providers and implant companies may want to devise innovative methods to increase market share.
5. Ann Arbor, Mich.-based Biotronic NeuroNetwork; Pittsburgh-based Computational Diagnostics; Dublin, Ireland-based Medtronic; Mundelein, Ill.-based Natus Medical; San Diego-based NuVasive; Hunt Valley, Md.-based Sentient Medical Systems; and Nashville, Tenn.-based SpecialtyCare lead the space.